Litigation Details for Cephalon, Inc. v. Aurobindo Pharma, Ltd. (D. Del. 2020)
✉ Email this page to a colleague
Cephalon, Inc. v. Aurobindo Pharma, Ltd. (D. Del. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-07-17 |
Court | District Court, D. Delaware | Date Terminated | 2020-07-31 |
Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | None | Referred To | |
Patents | 8,436,190; 8,609,863; 8,791,270; 8,895,756 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Cephalon, Inc. v. Aurobindo Pharma, Ltd.
Biologic Drugs cited in Cephalon, Inc. v. Aurobindo Pharma, Ltd.
Details for Cephalon, Inc. v. Aurobindo Pharma, Ltd. (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-07-17 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,436,190 B2 ;US 8,609,863 …2020 31 July 2020 1:20-cv-00962 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |